Bruker, Agilent Reach Deal on Varian Product Lines Purchase

The sale of the product lines to Bruker will clear the way for Agilent to complete its $1.5 billion acquisition of Varian, which is now expected by the end of April.

PGT Lands NIHR PGx Grant

The startup will study the reactions of 1,000 patients' genomes to certain chemotherapeutics.

Agilent Lands Aussie Distributor

Pacific Laboratory Products will distribute and support Agilent's line of chromatography columns and supplies in Australia.

Biocrates, Chenomx in Metabolic Profiling Technologies Alliance

The firms will combine their mass spec and NMR technologies for metabolomic applications.

Institute for Systems Biology Gets $6M Donation

An anonymous California venture capitalist and philanthropist has agreed to donate $6 million over five years to the Institute for Systems Biology.

NCI Seeks Molecular Signature Partnerships

The strategic partnerships will use multi-disciplinary research to study how multi-analyte signatures of tumors may be applied to cancer treatments.

ZenBio Licenses Metabolic Cell Line from Harvard

ZenBio will offer the cell lines in cryopreserved and cultured forms, as well as contract services including assay development and compound screening.

Pressure Biosciences, Target Discovery Partner on Tissue Prep

The companies are collaborating to develop, manufacture, and co-market reagents for use with membrane proteins for diagnostics, therapeutics, and vaccines.

Caliper's Q4 Revenues Increase 3 Percent

Caliper easily beat analysts' consensus estimate, which was expected after the firm pre-announced Q4 revenues in January. Its IVIS imaging products were the key driver of revenue growth for the quarter.

Biosearch Expands License to Roche IVD Patents

The license will expand Biosearch's participation in the diagnostics field from a provider of oligo components to a provider of kits.

NCI, ESTools License Integromics Software

The US cancer institute and the European stem cell consortium have inked site-wide licenses for the gene expression analysis software.

NINR to Fund Epigenetics of Chronic Illness Studies

Funded with $1.25 million in 2010, the grants will support studies of epigenetic factors that affect disease symptoms and complications.

NIH Plans $24M for Lung Cancer-COPD Genotype, Phenotype Studies

NCI and NHLBI plan to give $12 million each for research into molecular, genetic, and other connections between the two diseases.